Results 41 to 50 of about 58,795 (276)

Role of debulking mucoid ACL in unicompartmental knee arthroplasty: a prospective multicentric study

Knee Surgery & Related Research, 2022
Background Mucoid degeneration of the anterior cruciate ligament (ACL) has been shown to cause restricted terminal range of motion and rest pain. If present in a patient undergoing unicompartmental knee arthroplasty, it can deteriorate the final outcome.
Amyn M. Rajani, Urvil A. Shah, Anmol R. S. Mittal, Sheetal Gupta, Rajesh Garg, Meenakshi Punamiya   +5 more
doaj   +1 more source

Comparación histopatológica entre biopsia preoperatoria y debulking luego de la cirugía micrográfica de Mohs en carcinomas cutáneos

Revista Médica del Uruguay, 2022
Introducción: el subtipo histopatológico es uno de los determinantes fundamentales en la clasificación de riesgo de los carcinomas cutáneos. Surge de una biopsia incisional que representa solo un porcentaje de la masa tumoral, siendo la principal ...
Leticia Bermúdez, Romina Muguruza, Carlos Bazzano, Julio Magliano   +3 more
doaj   +1 more source

Hyperthermic intraperitoneal chemotherapy in interval debulking surgery for advanced epithelial ovarian cancer: A single‐center, real‐life experience

Cancer, 2020
An improvement in survival without increasing perioperative morbidity in patients with advanced epithelial ovarian cancer treated with hyperthermic intraperitoneal chemotherapy (HIPEC) after interval debulking surgery (IDS) has been recently demonstrated
V. Ghirardi, C. Ronsini, R. Trozzi, Chiara Di Ilio, A. di Giorgio, S. Cianci, G. Draisci, G. Scambia, A. Fagotti   +8 more
semanticscholar   +1 more source

Free flaps for lower limb soft tissue reconstruction in children : systematic review [PDF]

, 2019
A
CLAES, KAREL, De Wolf, Edward, Opsomer, Dries, Roche, Nathalie, Sommeling, Casper E, Van Landuyt, Koenraad   +5 more
core   +2 more sources

Study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer, SGOG SUNNY (SOC-2) trial concept

Journal of Gynecologic Oncology, 2020
Background Two randomized phase III trials (EORTC55971 and CHORUS) showed similar progression-free and overall survival in primary or interval debulking surgery in ovarian cancer, however both studies had limitations with lower rate of complete resection
R. Jiang, Jianqing Zhu, J. W. Kim, Jihong Liu, Kazuyoshi Kato, H. Kim, Yuqin Zhang, Ping Zhang, T. Zhu, D. Aoki, Aijun Yu, Xiaojun Chen, Xipeng Wang, Dingjun Zhu, Wei Zhang, Huixun Jia, Tingyan Shi, W. Gao, S. Yin, Yanling Feng, L. Xiang, A. Okamoto, R. Zang   +22 more
semanticscholar   +1 more source

Surgical treatment of a rare case of bilateral ptosis due to localized ocular amyloidosis [PDF]

, 2016
We describe a rare case of a 31-year old woman with bilateral ptosis due to localized amyloidosis. She referred a nine-year history of ptosis and surgical treatment with frontalis suspension three years previously.
ABDOLRAHIMZADEH, SOLMAZ, MAZZOCCHI, Marco, RECUPERO, Santi Maria, SCUDERI, GIANLUCA, TROCCOLA, Antonietta   +4 more
core   +1 more source

The accurate staging of ovarian cancer using 3T magnetic resonance imaging - a realistic option [PDF]

, 2008
Objectives: The aim of the study was to determine whether staging primary ovarian cancer using 3.0 Tesla (3T) magnetic resonance imaging (MRI) is comparable to surgical staging of the disease.
Booth, SJ, Poole, DR, Richmond, I, Turnbull, LW   +3 more
core   +1 more source

Debulking surgery for macrodystrophia lipomatosa of the lesser toe: a rare case report

Journal of International Medical Research, 2023
Macrodystrophia lipomatosa (MDL) is a rare disorder characterized by overgrowth of mesenchymal cells, resulting in gigantism of one or more digit. We report a case of a woman in her late 60s who presented with abnormal enlargement of the right second toe.
Sung Hyun Lee, Yang Hun Jo
doaj   +1 more source

Clinical significance of primary debulking surgery and neoadjuvant chemotherapy-interval debulking surgery in advanced ovarian cancer.

Japanese Journal of Clinical Oncology, 2020
Primary debulking surgery followed by platinum-based chemotherapy remains the standard treatment of patients with stage III-IV epithelial ovarian cancer.
S. Nishio, K. Ushijima
semanticscholar   +1 more source

HIPEC after Interval Debulking Surgery as Best Clinical Practice in Ovarian Cancer Patients: Case Series and Literature Review

Clinical and Experimental Obstetrics & Gynecology, 2022
Background: Hyperthermic intraperitoneal chemotherapy (HIPEC) combined with interval debulking surgery (IDS) constitutes an adjunctive treatment strategy in advanced ovarian cancer (AOC).
Stefano Restaino, Jessica Mauro, Stefano Cianci, Alessandro Buda, Claudia Andreetta, Elena Poletto, Enrico Maria Pasqual, Alice Poli, Cosimo Vittorio Agrimi, Doriana Armenise, Alice Buzzelli, Domenico Caccamo, Lorenza Driul, Giuseppe Vizzielli   +13 more
doaj   +1 more source